(Press-News.org) One major cause of illness from food-borne diseases is the parasite Toxoplasma gondii (T. gondii). New insights into how the immune system combats T. gondii are provided in a study published by Cell Press December 13th in the journal Immunity. The findings could lead to the development of long-sought vaccines to protect against T. gondii and related parasites.
To fight off pathogens, the immune system relies on Toll-like receptors (TLRs)—a class of proteins that recognize microbes and activate immune responses. The important role of TLR11 in recognizing the T. gondii infection was previously demonstrated by a team led by Sankar Ghosh of Columbia University and Alan Sher of the National Institute of Allergy and Infectious Diseases. But scientists had not yet identified any TLRs—including TLR11—that could promote survival in infected animals.
VIDEO:
This shows Toxoplasma gondii tachyzoites egressing from an infected fibroblast and invading new cells.
Click here for more information.
In the new study, Ghosh, Sher, and their collaborators focused on the previously uncharacterized TLR12 because it is closely related to TLR11 and physically interacts with that receptor, suggesting that the two might work together to mount immune responses. When they genetically engineered mice to lack TLR12, they found that immune cells could not recognize or protect against T. gondii, and these mice quickly succumbed to infection. Although both TLR11 and TLR12 activate overlapping immune responses to T. gondii in certain types of cells, TLR12 also triggers responses in a distinct set of immune cells to promote survival.
"Prior to this study, TLR12 had no known function in the immune system, and it was not known what pathogen this receptor recognized," Ghosh says. "We have demonstrated that TLR12 is essential for resistance to T. gondii in mice."
Because TLR12 also recognized another related parasite, the findings could have broad clinical implications. "By investigating how immune cells expressing TLR12 organize the immune response against T. gondii infection, we hope to identify new means of promoting protective immune responses against T. gondii and potentially other important parasite pathogens," Ghosh says.
INFORMATION:
Koblansky et al.: "Recognition of profilin by toll-like receptor 12 is critical for host resistance to Toxoplasma gondii."
New study brings long-sought vaccines for deadly parasite closer to reality
2012-12-13
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Ability to sit and rise from the floor is closely correlated with all-cause mortality risk
2012-12-13
A simple screening test of musculo-skeletal fitness has proved remarkably predictive of all-cause mortality in a study of more than 2000 middle-aged and older men and women. The study, performed in Brazil by Dr Claudio Gil Araújo and colleagues at the Clinimex - Exercise Medicine Clinic in Rio de Janeiro, is reported today in the European Journal of Cardiovascular Prevention.(1,2)
The test was a simple assessment of the subjects' ability to sit and then rise unaided from the floor. The assessment was performed in 2002 adults of both sexes and with ages ranging from 51 ...
New screening approach identified potential drug combos for difficult-to-treat melanomas
2012-12-13
PHILADELPHIA — A novel approach to identifying potential anticancer drug combinations revealed that pairing cholesterol-reducing drugs called statins with cyclin-dependent kinase inhibitors might provide an effective approach to treating intractable melanomas driven by mutations in the NRAS and KRAS gene.
David F. Stern, Ph.D., professor of pathology at Yale University School of Medicine in New Haven, Conn., and colleagues reported these data in Cancer Discovery, a journal of the American Association for Cancer Research.
"The identification of gene mutations that ...
Cancer stem cells isolated from kidney tumors
2012-12-13
Scientists have isolated cancer stem cells that lead to the growth of Wilms' tumours, a type of cancer typically found in the kidneys of young children. The researchers have used these cancer stem cells to test a new therapeutic approach that one day might be used to treat some of the more aggressive types of this disease. The results are published online in EMBO Molecular Medicine.
"In earlier studies, cancer stem cells were isolated from adult cancers of the breast, pancreas and brain but so far much less is known about stem cells in paediatric cancers," remarked Professor ...
Intestinal immune cells play an unexpected role in immune surveillance of the bloodstream
2012-12-13
A type of immune cell found in the small intestine plays a previously unsuspected role in monitoring antigens circulating in the bloodstream. The findings from a team of Massachusetts General Hospital (MGH) researchers clarify how dendritic cells in the intestinal lining collect antigens from both intestinal contents and the circulation, leading to the generation of T cells that suppress inflammation. Disruption of that regulatory system may lead to the development of autoimmune disorders, inflammatory bowel disease or food allergies.
"In the circuitry we uncovered, ...
Cleveland Clinic researcher identifies 2 new genetic mutations associated with Cowden syndrome
2012-12-13
Thursday, December 13, 2012, Cleveland: Cleveland Clinic researchers from the Lerner Research Institute have uncovered two new genes associated with Cowden syndrome (CS) according to a new study, published today in the online version of the American Journal of Human Genetics.
Cowden syndrome is a difficult-to-recognize, under-diagnosed condition that carries high risks of breast, thyroid, and other cancers. The discovery of the two new genes – led by Charis Eng, MD, Ph.D., Chair and Founding Director of the Cleveland Clinic's Lerner Research Institute's Genomic Medicine ...
Massive shifts reshape the health landscape worldwide
2012-12-13
LONDON – Globally, health advances present most people with a devastating irony: avoid premature death but live longer and sicker.
That's one of the main findings from the Global Burden of Disease Study 2010 (GBD 2010), a collaborative project led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. The findings are being announced at the Royal Society in London on Dec. 14 and published in The Lancet, the first time the journal has dedicated an entire triple issue to one study. The seven scientific papers and accompanying commentaries ...
Blood pressure, smoking and alcohol: The health risks with the biggest global burden
2012-12-13
Over 9 million people died as a consequence of high blood pressure in 2010, making it the health risk factor with the greatest toll worldwide, say experts.
Smoking and alcohol use have also overtaken child hunger in the last two decades to become the second and third leading risks globally, according to a study estimating the disease burden attributable to 43 risk factors in 1990 and 2010.
The analysis was undertaken by an international consortium of scientists as part of the Global Burden of Disease Study 2010, which is published in The Lancet today.
"Overall we're ...
Study finds years living with disease, injury increasing globally
2012-12-13
Boston, MA — No matter where they live, how much education they have, or what their incomes are, people have very similar perceptions on the impact of diseases and injuries.
This finding – counter to the prevailing belief that people throughout the world view different health conditions in very different ways depending on their culture or individual circumstances – is part of a collaborative project, the Global Burden of Disease Study 2010 (GBD 2010). GBD 2010, launched by Harvard School of Public Health (HSPH), the Institute for Health Metrics and Evaluation (IHME) ...
Viruses cooperate or conquer to cause maximum destruction
2012-12-13
Scientists have discovered new evidence about the evolution of viruses, in work that will change our understanding about the control of infectious diseases such as winter flu.
Researchers at the University of Exeter's conducted experiments to manipulate a virus to see if it could evolve the ability to switch its behaviour according to how many other viruses infect a host.
Previous research has focussed on trying to force harmful microbes to become less threatening to human health as they evolve. But the new research, which was carried out in collaboration with the ...
Millions of patients still waiting for medical 'breakthroughs' against neglected diseases
2012-12-13
New York, NY, December 13, 2012— Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/Médecins Sans Frontières (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed ...